The issue as to whether the new, so-called “right-to-try” legislation is a good idea or not is contentious and your sitemaster has no interest in getting into that discussion. What is a fact is that it has now been signed into law. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: "right to try", access, bill, drug, investigational, law | 2 Comments »
As many of our readers may be aware, the “right to try” treatments using investigational new drugs outside of the clinical trials processes required by drug developers and overseen by the US Food and Drug Administration is a current “hot topic” on Capitol Hill. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: "right to try", investigational, Legislation, off-label, Treatment, unapproved | Leave a comment »
If you look at the corporate web site for eviCore Healthcare, the company describes itself as follows: … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: classification, experimenta;l, guideline, investigational | 6 Comments »
Yet another set of researchers have found yet another possible new drug that seems to have significant activity in management of prostate cancer — in mice! Whether it will have activity in men is a whole other question. … READ MORE …
Filed under: Drugs in development, Management | Tagged: active, drug, investigational, IPA-3, mice | 4 Comments »
Earlier this year (on March 29 to be precise) some of our readers may remember seeing a two-part 60 Minutes program about the use of a modified form of poliovirus in the successful treatment of some patients with deadly forms of brain cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: investigational, modified, poliovirus | 3 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 